# Bayer and CrossBay Medical partner to develop novel IUS inserter

Bayer and CrossBay Medical Inc. announced a development and option to license agreement to develop and produce a single-handed inserter combined with Bayer's hormonal intrauterine systems (IUSs), using CrossBay's CrossGlide technology. The deal was announced on November 30, 2023.

- Type: Partnership
- Announced: 2023-11-30
- Status: announced
- Products: intrauterine system inserter, CrossGlide technology, hormonal IUS
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bayer](https://endata.com/companies/2148.md) (partner)
- [CrossBay Medical Inc.](https://endata.com/companies/74101.md) (partner)

## Sources

- [bayer.com](https://www.bayer.com/media/en-us/bayer-and-crossbay-medical-to-develop-novel-intrauterine-system-inserter/), 2023-11-30: "Partnering with CrossBay Medical has the potential to offer women an opportunity to consider the full range of contraceptive options available."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.